Sitemap - 2022 - Mendelspod
The Bioengineered Hangover Cure: Changing the Conversation around GMOs with Zack Abbott of ZBiotics
Lance Baldo of Freenome on their Approach to Early Cancer Detection
Terry Lo of Vizgen on Spatial Genomics
Proteomics at Scale Empowers Genomics in New Ways: Dale Yuzuki, Olink
A New Tool in the Genomics Kit with Ivan Liachko of Phase Genomics
Paul Kruszka of GeneDx/Sema4 on Groundbreaking Newborn Sequencing Study
Is PGx Having a Moment? Kristine Ashcraft, Invitae
Christian Henry on Revio, Onso and the New Vision at PacBio
The Revolution in Single Molecule Sequencing Continues: Vijay Ramani, UCSF
Will Hwang of Mass General on Discovery of Novel Pancreatic Cancer Cell Subtype
Going Beyond Time Barriers: Arutha Kulasinghe on the Power of New Spatial Biology Tools
Invitae’s Data Manager, Farid Vij, on New Genome Management Platform
Satellite Bio out with a New Tissue Based Approach to Regenerative Medicine
We Have to Get Sequencing Back to Moore’s Law: Gilad Almogy, Ultima Genomics
RNA Therapeutics: A New Paradigm for Drug Development? Tim Mercer, BASE Lab, U of Queensland
The Promise of Exosomes Now Realized, Says Paul Billings, CEO, Biological Dynamics
Lee Cronin on Origin of Life, Genomics, Aliens and More
Eric Green on the Future of the NHGRI
5-Base Sequencing: Jonas Korlach and Tomi Pastinen
More Cancer Patients Die from Infections than Cancer, Says Alec Ford, CEO of Karius
Some of the Lowest Hanging Fruits in Precision Medicine: Michelle Whirl-Carrillo on Pharmacogenomics
John Nelson of GE Research Talks Vaccines on Demand, Enzymatic Synthesis, and the Era of Writing DNA
Enabling a New Age of Unbiased Proteomics Discovery: Omid Farokhzad, Seer Inc.
The Rise of MRD Testing and the Field of Fragmentomics with Sugganth Daniel, Invitae
The Invention of Enzymatic DNA Synthesis with Sylvain Gariel, DNA Script
Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity
Twist Bioscience: A New Kind of DNA Synthesis Company
Going High Resolution with 10X Genomics: Michael Schnall-Levin
George Church and Ben Lamm on the Launch of Colossal Biosciences